FOXP3 and neoplasm: Recent reports suggested that thymic-derived CD4+CD25+ regulatory T cells (Treg; Foxp3+ lymphocytes) participate in the control of tumour immunity, but whether Treg control tumour immunity in OSCC has not been established.